메뉴 건너뛰기
Therapeutic Delivery
Volumn 1, Issue 5, 2010, Pages 615-619
Personalized medicine: Transforming drug development and healthcare
Author keywords

barriers to personalized medicine; genomics; lifestyle; variability in drug response
Indexed keywords

BIOLOGICAL MARKER;
EID: 79954532774     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.10.68     Document Type: Review
Times cited : (11)
References (13)
  • 1
    • 79954460014 scopus 로고    scopus 로고
    • Characterizing markets for biopharmaceutical innovations: Do biologics differ from small molecules?
    • Trusheim MR, Aitken ML, Berndt ER. Characterizing markets for biopharmaceutical innovations: do biologics differ from small molecules? Forum Health Econ. Policy 13(1), article 4, (2010).
    • (2010) Forum Health Econ Policy , vol.13 , Issue.1 , pp. 4
    • Trusheim, M.R.1    Aitken, M.L.2    Berndt, E.R.3
  • 2
    • 33745954240 scopus 로고    scopus 로고
    • Diagnostics and biomarker development: Priming the pipeline
    • DOI 10.1038/nrd2033, PII NRD2033
    • Phillips K, Van Bebber S, Issa AM. Diagnostics and biomarker development: priming the pipeline. Nat. Rev. Drug Discov. 5, 463-469 (2006). (Pubitemid 44136958)
    • (2006) Nature Reviews Drug Discovery , vol.5 , Issue.6 , pp. 463-469
    • Phillips, K.A.1    Van Bebber, S.2    Issa, A.M.3
  • 3
    • 77956429360 scopus 로고    scopus 로고
    • The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer
    • Lammers L, Mathijssen RH, van Gelder T, et al. The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer. Br. J. Cancer 103, 765-771 (2010).
    • (2010) Br. J. Cancer , vol.103 , pp. 765-771
    • Lammers, L.1    Mathijssen, R.H.2    Van Gelder, T.3
  • 4
    • 34547656228 scopus 로고    scopus 로고
    • The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates
    • DOI 10.1038/nrd2378, PII NRD2378
    • Kramer J, Sagartz JE, Morris DL. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nat. Rev. Drug Discov. 6, 636-649 (2007). (Pubitemid 47207750)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.8 , pp. 636-649
    • Kramer, J.A.1    Sagartz, J.E.2    Morris, D.L.3
  • 5
    • 70450149001 scopus 로고    scopus 로고
    • Current understanding of the pharmacogenomics of metformin
    • Zolk O. Current understanding of the pharmacogenomics of metformin. Clin. Pharm. Ther. 86, 595-8 (2009).
    • (2009) Clin. Pharm. Ther. , vol.86 , pp. 595-598
    • Zolk, O.1
  • 6
    • 34247247181 scopus 로고    scopus 로고
    • Macroscopy regulation: Individualization of medicine lost in translation
    • Wilson C, Schulz S, Waldman SA. Macroscopy regulation: individualization of medicine lost in translation. Clin. Pharm. Ther. 81, 153-155 (2007).
    • (2007) Clin. Pharm. Ther. , vol.81 , pp. 153-155
    • Wilson, C.1    Schulz, S.2    Waldman, S.A.3
  • 8
    • 33847666051 scopus 로고    scopus 로고
    • Personalized medicine: Building the GPS to take us there
    • Ratain MJ. Personalized medicine: building the GPS to take us there. Clin. Pharm. Ther. 81, 1-2 (2007).
    • (2007) Clin. Pharm. Ther. , vol.81 , pp. 1-2
    • Ratain, M.J.1
  • 9
    • 77950190617 scopus 로고    scopus 로고
    • Patient-tailored therapy in rheumatoid arthritis: An editorial review
    • Scherer HU, Dörner T, Burmester GR. Patient-tailored therapy in rheumatoid arthritis: an editorial review. Curr. Opin. Rheu. 22, 237-45 (2010).
    • (2010) Curr. Opin. Rheu. , vol.22 , pp. 237-245
    • Scherer, H.U.1    Dörner, T.2    Burmester, G.R.3
  • 10
    • 24944547571 scopus 로고    scopus 로고
    • Why drugs fail - A study on side effects in new chemical entities
    • DOI 10.2174/138161205774414510
    • Schuster D, Laggner C, Langer T. Why drugs fail - a study on side effects in new chemical entities. Curr. Pharm. Design 11, 3545-3559 (2005). (Pubitemid 41300759)
    • (2005) Current Pharmaceutical Design , vol.11 , Issue.27 , pp. 3545-3559
    • Schuster, D.1    Laggner, C.2    Langer, T.3
  • 11
    • 77957017871 scopus 로고    scopus 로고
    • The development of new therapeutics for Alzheimer's disease
    • Carter MD, Simms G, Weaver DF. The development of new therapeutics for Alzheimer's disease. Clin. Pharm. Ther. 88(4 475-486 (2010).
    • (2010) Clin. Pharm. Ther. , vol.88 , Issue.4 , pp. 475-486
    • Carter, M.D.1    Simms, G.2    Weaver, D.F.3
  • 12
    • 77957066281 scopus 로고    scopus 로고
    • A serum protein-based algorithm for the detection of Alzheimer's disease
    • O'Bryant S, Xiao G, Barber R, et al. A serum protein-based algorithm for the detection of Alzheimer's disease. Arch. Neurol. 67, 1077-1081 (2010).
    • (2010) Arch. Neurol. , vol.67 , pp. 1077-1081
    • O'Bryant, S.1    Xiao, G.2    Barber, R.3
  • 13
    • 85157039589 scopus 로고    scopus 로고
    • PharmGKB. www.pharmgkb.org
    • PharmGKB

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.